Inhibition of Colon Cancer (HT-29) Cell Proliferation by a Triterpenoid Isolated from Azadirachta indica is Accompanied by Cell Cycle Arrest and Up-Regulation of p21

Abstract

Nimbolide, a natural triterpenoid present in the edible parts of the neem tree (Azadirachta indica), was found to be growth-inhibitory in human colon carcinoma HT-29 cells. Nimbolide treatment of cells at 2.5 - 10 μM resulted in moderate to very strong growth inhibition. Flow cytometric analysis of HT-29 cells showed that nimbolide treatment (2.5 μM, 12 h) caused a 6.5-fold increase in the number of cells (55.6 %) in the G2/M phase compared with the control cells (8.8 %). At 48 h, the cell population in the G2/M phase decreased to 18 %, while that in the G0/G1 phase increased to 52.3 %. Western blot analysis revealed that nimbolide-mediated G2/M arrest was accompanied by the up-regulation of p21, cyclin D2, Chk2; and down-regulation of cyclin A, cyclin E, Cdk2, Rad17. At G0/G1 cell cycle arrest, modulation in the expression of the cell cycle regulatory molecules was also observed. We found that nimbolide-induced growth inhibition and cell cycle arrest were not associated with cellular differentiation. Quantification of cells with respect to the expression of phosphatidylserine in the outer cell membrane showed an increase in apoptotic cells by about 13 % after 48 h of nimbolide treatment.

Key words

Nimbolide - colon cancer - G0/G1 arrest - G2/M arrest - p21

References

• 1 Keating B. Neem: The miraculous healing Herb. Winter Park: The neem association 1994
• 2 Biswas K, Chattopadhyay I, Banerjee R K, Bandhopadhyay U. Biological activities and medicinal properties of Neem (Azadirachta indica).  Curr Sci. 2002;  82 1336-45
• 3 Cohen E, Quistad G B, Casida J E. Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticide.  Life Sci. 1996;  58 1075-81
• 4 Glinsukon T, Somjaree R, Piyachaturawat P, Thebtaranonth Y. Acute toxicity of nimbolide and nimbic acid in mice, rats and hamsters.  Toxicol Lett. 1986;  30 159-66
• 5 Martinez M E. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise.  Recent Results Cancer Res. 2005;  166 177-211
• 6 Cohen E, Quistad G B, Jeffries P R, Casida J E. Nimbolide is the principal cytotoxic component of neem seed insecticide preparations.  Pestic Sci. 1996;  48 135-40
• 7 Kigodi P G, Blasko G, Thebtaranonth Y, Pezzuto J M, Cordell G A. Spectroscopic and biological investigation of nimbolide and 28-deoxonimbolide from Azadirachta indica .  J Nat Prod. 1989;  52 1246-51
• 8 Reese D H, Fiorentino G J, Claflin A J, Malinin T I, Politano V A. Rapid induction of alkaline phosphatase activity by retinoic acid.  Biochem Biophys Res Commun. 1981;  102 315-21
• 9 Cayrol C, Knibiehler M, Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.  Oncogene. 1998;  16 311-20
• 10 Medema R H, Klompmaker R, Smits V A, Rijksen G. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.  Oncogene. 1998;  16 431-41
• 11 LaBaer J, Garrett M D, Stevenson L F, Slingerland J M, Sandhu C, Chou H S. et al . New functional activities for the p21 family of CDK inhibitors.  Genes Dev. 1997;  11 847-62
• 12 Cheng M, Olivier P, Diehl J A, Fero M, Roussel M F, Roberts J M. et al . The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts.  EMBO J. 1999;  18 1571-83
• 13 Sherr C J. Cancer cell cycles.  Science. 1996;  274 1672-7
• 14 Morgan D O. Principles of CDK regulation.  Nature. 1995;  374 131-4
• 15 Ding Q M, Ko T C, Evers B M. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.  Am J Physiol. 1998;  275 C1193-200
• 16 Xiong Y, Hannon G J, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases.  Nature. 1993;  366 701-4
• 17 Zeng Y X, el-Deiry W S. Regulation of p21WAF1/CIP1 expression by p53-independent pathways.  Oncogene. 1996;  12 1557-64
• 18 Cappelletti V, Fioravanti L, Miodini P, Di Fronzo G. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle.  J Cell Biochem. 2000;  79 594-600
• 19 Kehn K, Deng L, De La Fuente C, Strouss K, Wu K, Maddukuri A. et al . The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells.  Retrovirology. 2004;  1 1-6
• 20 Sanchez Y, Wong C, Thoma R S, Richman R, Wu Z, Piwnica-Worms H. et al . Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.  Science. 1997;  277 1497-501
• 21 Matsuoka S, Huang M, Elledge S J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.  Science. 1998;  282 1893-7
• 22 Hirao A, Kong Y Y, Matsuoka S, Wakeham A, Ruland J, Yoshida H. et al . DNA damage-induced activation of p53 by the checkpoint kinase Chk2.  Science. 2000;  287 1824-7
• 23 Parsels L A, Parsels J D, Tai D C-H, Coughlin D J, Maybaum J. 5-Fluoro-2"-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.  Cancer Res. 2004;  64 6588-94
• 24 Chang K L, Kung M L, Chow N H, Su S J. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1.  Biochem Pharmacol. 2004;  67 717-26
• 25 Sancar A, Lindsey-Boltz L A, Unsal-Kaccmaz K, Linn S. Molecular mechanism of mammalian DNA repair and the DNA damage checkpoints.  Annu Rev Biochem. 2004;  73 39-85
• 26 Chinni S R, Li Y, Upadhyay S, Koppolu P K, Sarkar F H. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.  Oncogene. 2001;  20 2927-36
• 27 Moragoda L, Jaszewski R, Majumdar A P. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells.  Anticancer Res. 2001;  21 873-8